309 related articles for article (PubMed ID: 24017968)
1. Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.
Arvikar SL; Collier DS; Fisher MC; Unizony S; Cohen GL; McHugh G; Kawai T; Strle K; Steere AC
Arthritis Res Ther; 2013; 15(5):R109. PubMed ID: 24017968
[TBL] [Abstract][Full Text] [Related]
2. Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis.
Kobayashi T; Ito S; Kobayashi D; Shimada A; Narita I; Murasawa A; Nakazono K; Yoshie H
PLoS One; 2016; 11(4):e0154182. PubMed ID: 27111223
[TBL] [Abstract][Full Text] [Related]
3. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis.
Johansson L; Sherina N; Kharlamova N; Potempa B; Larsson B; Israelsson L; Potempa J; Rantapää-Dahlqvist S; Lundberg K
Arthritis Res Ther; 2016 Sep; 18(1):201. PubMed ID: 27605245
[TBL] [Abstract][Full Text] [Related]
4. Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults.
Okada M; Kobayashi T; Ito S; Yokoyama T; Komatsu Y; Abe A; Murasawa A; Yoshie H
J Periodontol; 2011 Oct; 82(10):1433-41. PubMed ID: 21342003
[TBL] [Abstract][Full Text] [Related]
5. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.
Mikuls TR; Payne JB; Yu F; Thiele GM; Reynolds RJ; Cannon GW; Markt J; McGowan D; Kerr GS; Redman RS; Reimold A; Griffiths G; Beatty M; Gonzalez SM; Bergman DA; Hamilton BC; Erickson AR; Sokolove J; Robinson WH; Walker C; Chandad F; O'Dell JR
Arthritis Rheumatol; 2014 May; 66(5):1090-100. PubMed ID: 24782175
[TBL] [Abstract][Full Text] [Related]
6. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.
Mikuls TR; Thiele GM; Deane KD; Payne JB; O'Dell JR; Yu F; Sayles H; Weisman MH; Gregersen PK; Buckner JH; Keating RM; Derber LA; Robinson WH; Holers VM; Norris JM
Arthritis Rheum; 2012 Nov; 64(11):3522-30. PubMed ID: 22736291
[TBL] [Abstract][Full Text] [Related]
7. Association of Anti-Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid Arthritis.
Seror R; Le Gall-David S; Bonnaure-Mallet M; Schaeverbeke T; Cantagrel A; Minet J; Gottenberg JE; Chanson P; Ravaud P; Mariette X
Arthritis Rheumatol; 2015 Jul; 67(7):1729-37. PubMed ID: 25779552
[TBL] [Abstract][Full Text] [Related]
8. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
Konig MF; Paracha AS; Moni M; Bingham CO; Andrade F
Ann Rheum Dis; 2015 Nov; 74(11):2054-61. PubMed ID: 24864075
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.
Li S; Yu Y; Yue Y; Liao H; Xie W; Thai J; Mikuls TR; Thiele GM; Duryee MJ; Sayles H; Payne JB; Klassen LW; O'Dell JR; Zhang Z; Su K
Arthritis Rheumatol; 2016 Mar; 68(3):614-26. PubMed ID: 26474325
[TBL] [Abstract][Full Text] [Related]
10. Oral and Intestinal Bacterial Substances Associated with Disease Activities in Patients with Rheumatoid Arthritis: A Cross-Sectional Clinical Study.
Kitamura K; Shionoya H; Suzuki S; Fukai R; Uda S; Abe C; Takemori H; Nishimura K; Baba H; Katayama K; Terato K; Waritani T
J Immunol Res; 2022; 2022():6839356. PubMed ID: 35224112
[TBL] [Abstract][Full Text] [Related]
11. Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis.
Molad Y; Ofer-Shiber S; Pokroy-Shapira E; Oren S; Shay-Aharoni H; Babai I
Eur J Clin Invest; 2015 Jun; 45(6):557-64. PubMed ID: 25832796
[TBL] [Abstract][Full Text] [Related]
12. Bacterial citrullinated epitopes generated by
Jenning M; Marklein B; Ytterberg J; Zubarev RA; Joshua V; van Schaardenburg D; van de Stadt L; Catrina AI; Nonhoff U; Häupl T; Konthur Z; Burmester GR; Skriner K
Ann Rheum Dis; 2020 Sep; 79(9):1194-1202. PubMed ID: 32532752
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
Strollo R; Ponchel F; Malmström V; Rizzo P; Bombardieri M; Wenham CY; Landy R; Perret D; Watt F; Corrigall VM; Winyard PG; Pozzilli P; Conaghan PG; Panayi GS; Klareskog L; Emery P; Nissim A
Arthritis Rheum; 2013 Jul; 65(7):1702-12. PubMed ID: 23575908
[TBL] [Abstract][Full Text] [Related]
18. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
Bruns A; Nicaise-Roland P; Hayem G; Palazzo E; Dieudé P; Grootenboer-Mignot S; Chollet-Martin S; Meyer O
Joint Bone Spine; 2009 May; 76(3):248-53. PubMed ID: 19208451
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
Lundberg K; Kinloch A; Fisher BA; Wegner N; Wait R; Charles P; Mikuls TR; Venables PJ
Arthritis Rheum; 2008 Oct; 58(10):3009-19. PubMed ID: 18821669
[TBL] [Abstract][Full Text] [Related]
20. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
